Anacor Pharmaceuticals
Pharmaceutical ManufacturingView the employees at
Anacor Pharmaceuticals-
ismail korkmaz atolye / Anacor Pharmaceuticals
-
Yozgat, Turkey
-
Rising Star
Anh Antonio Human Resources Manager at Anacor Pharmaceuticals-
Palo Alto, California, United States
-
Rising Star
Cheryl Justi Executive Assistant at Rambus-
Rising Star
El Bonn Ahmed Mahmoud Directeur des Ressources Humainnes chez ANAC (Agence Nationale de L'aviation Civile) de MAURITANIE-
Mauritania
-
Rising Star
Sandy Zhao Shareholders of Anacor Pharmaceuticals, Inc.-
Beverly Hills, California, United States
-
Top 5%
Overview
Anacor was a biopharmaceutical company focused on discovering, developing and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. Anacor has discovered and is developing five clinical compounds, including its three lead programs: AN2690, a topical antifungal for the treatment of onychomycosis; AN2728, a topical anti-inflammatory PDE-4 inhibitor for the treatment of psoriasis; and GSK 2251052, or GSK '052 (formerly referred to as AN3365), a systemic antibiotic for the treatment of infections caused by Gram-negative bacteria, which has been licensed to GlaxoSmithKline under the companies' research and development agreement. In addition, Anacor is developing AN2718 as a topical antifungal product candidate for the treatment of onychomycosis and skin fungal infections, and AN2898 as a topical anti-inflammatory product candidate for the treatment of psoriasis and atopic dermatitis.
-